Claudia Ordonez, MD
Enriched profileSenior Vice President, Medical Science, CervoMed Inc. · CervoMed Inc.
Claudia Ordonez is Senior Vice President, Medical Science, CervoMed Inc. at CervoMed Inc.. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 31 Aug 2026
Claudia L. Ordoñez, MD, is Senior Vice President, Medical Science, CervoMed Inc.. The public record shows 30 publications with 7,625 citations (h-index 19), centered on Cystic Fibrosis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 2 companies, 3 NIH-funded awards (2000–2007).
- Top research focus: Cystic Fibrosis
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects
Sponsor: Flatley Discovery Lab LLC
- A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects
Sponsor: Flatley Discovery Lab LLC
- A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants
Sponsor: Flatley Discovery Lab LLC
Industry payments
Updated 31 Aug 2026
2 companies reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:
- Ipsen Bioscience Inc.Program year20251 payment
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
- Ipsen Bioscience Inc.Program year20248 payments$72,625openpaymentsdata.cms.gov ↗
NIH funding
Updated 31 Aug 2026
3 NIH research awards on record, funded 2000–2007 per NIH RePORTER. The latest:
- Phase 2 study of VX-770 in Cystic Fibrosis Subjectswith G551D
Vertex Pharmaceuticals, Inc.
FY2007$350,000R01FD003432 - P aeruginosa virulence in cystic fibrosis lung disease
Boston Children'S Hospital
FY2006$154,683K23HL075502 - ASSESSMENT OF INDUCED SPUTUM AS A TOOL TO EVALUATE ANTI-INFLAMMATORY AGENTS
Boston Children'S Hospital
FY2006$8,124M01RR002172
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIV
Open Forum Infectious Diseases
2023 - EPS3.06 Safety, pharmacokinetics and pharmacodynamics of the CFTR corrector FDL169
Journal of Cystic Fibrosis
2018
Online presence
Updated 31 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/claudia-ordonez-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- B.A. in Biology
University of Maryland, Baltimore County
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →people.equilar.com ↗
Editorial & leadership roles
journal and society appointments- Clinical Instructor in Pediatrics
Boston Children's Hospital (historical, CF-focused academic appointment)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →people.equilar.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →people.equilar.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →people.equilar.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm